Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 470

1.

National Association of Psychometrists: 2015 professional practices and salary survey of U.S. and Canadian psychometrists.

Kippie A, Ryan BJ, McManemy H, Escobar Medina MR, Porter PM, Malek-Ahmadi M.

Clin Neuropsychol. 2018 May 11:1-19. doi: 10.1080/13854046.2018.1472297. [Epub ahead of print]

PMID:
29749793
2.

Alcohol, Smoking, and Risk of Her2-Overexpressing and Triple-Negative Breast Cancer Relative to Estrogen Receptor-Positive Breast Cancer.

Baglia ML, Cook LS, Tang MT, Wiggins C, Hill D, Porter P, Li CI.

Int J Cancer. 2018 Apr 30. doi: 10.1002/ijc.31575. [Epub ahead of print]

PMID:
29708591
3.

Tumor-Infiltrating Lymphocytes and PD-L1 Expression in Pre- and Posttreatment Breast Cancers in the SWOG S0800 Phase II Neoadjuvant Chemotherapy Trial.

Pelekanou V, Barlow WE, Nahleh ZA, Wasserman B, Lo YC, von Wahlde MK, Hayes D, Hortobagyi GN, Gralow J, Tripathy D, Porter P, Szekely B, Hatzis C, Rimm DL, Pusztai L.

Mol Cancer Ther. 2018 Mar 27. doi: 10.1158/1535-7163.MCT-17-1005. [Epub ahead of print]

PMID:
29588392
4.

Benefits of antifungal therapy in asthma patients with airway mycosis: A retrospective cohort analysis.

Li E, Tsai CL, Maskatia ZK, Kakkar E, Porter P, Rossen RD, Perusich S, Knight JM, Kheradmand F, Corry DB.

Immun Inflamm Dis. 2018 Jun;6(2):264-275. doi: 10.1002/iid3.215. Epub 2018 Mar 25.

5.

The Women's Health Initiative (WHI) Life and Longevity After Cancer (LILAC) Study: Description and Baseline Characteristics of Participants.

Paskett ED, Caan BJ, Johnson L, Bernardo BM, Young GS, Pennell ML, Ray RM, Kroenke CH, Porter PL, Anderson GL.

Cancer Epidemiol Biomarkers Prev. 2018 Feb;27(2):125-137. doi: 10.1158/1055-9965.EPI-17-0581. Epub 2018 Jan 29.

PMID:
29378785
6.

Family History and Risk of Second Primary Breast Cancer after In Situ Breast Carcinoma.

Baglia ML, Tang MC, Malone KE, Porter P, Li CI.

Cancer Epidemiol Biomarkers Prev. 2018 Mar;27(3):315-320. doi: 10.1158/1055-9965.EPI-17-0837. Epub 2018 Jan 16.

PMID:
29339357
7.

Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data.

Campbell BCV, van Zwam WH, Goyal M, Menon BK, Dippel DWJ, Demchuk AM, Bracard S, White P, Dávalos A, Majoie CBLM, van der Lugt A, Ford GA, de la Ossa NP, Kelly M, Bourcier R, Donnan GA, Roos YBWEM, Bang OY, Nogueira RG, Devlin TG, van den Berg LA, Clarençon F, Burns P, Carpenter J, Berkhemer OA, Yavagal DR, Pereira VM, Ducrocq X, Dixit A, Quesada H, Epstein J, Davis SM, Jansen O, Rubiera M, Urra X, Micard E, Lingsma HF, Naggara O, Brown S, Guillemin F, Muir KW, van Oostenbrugge RJ, Saver JL, Jovin TG, Hill MD, Mitchell PJ; HERMES collaborators.

Lancet Neurol. 2018 Jan;17(1):47-53. doi: 10.1016/S1474-4422(17)30407-6. Epub 2017 Dec 16.

PMID:
29263006
8.

Bisphosphonate Use and Risk of Recurrence, Second Primary Breast Cancer, and Breast Cancer Mortality in a Population-Based Cohort of Breast Cancer Patients.

Korde LA, Doody DR, Hsu L, Porter PL, Malone KE.

Cancer Epidemiol Biomarkers Prev. 2018 Feb;27(2):165-173. doi: 10.1158/1055-9965.EPI-17-0556. Epub 2017 Dec 18.

PMID:
29254937
9.

Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.

Cardoso F, Bartlett JMS, Slaets L, van Deurzen CHM, van Leeuwen-Stok E, Porter P, Linderholm B, Hedenfalk I, Schröder C, Martens J, Bayani J, van Asperen C, Murray M, Hudis C, Middleton L, Vermeij J, Punie K, Fraser J, Nowaczyk M, Rubio IT, Aebi S, Kelly C, Ruddy KJ, Winer E, Nilsson C, Dal Lago L, Korde L, Benstead K, Bogler O, Goulioti T, Peric A, Litière S, Aalders KC, Poncet C, Tryfonidis K, Giordano SH.

Ann Oncol. 2018 Feb 1;29(2):405-417. doi: 10.1093/annonc/mdx651.

PMID:
29092024
10.

Cough sound analysis for diagnosing croup in pediatric patients using biologically inspired features.

Sharan RV, Abeyratne UR, Swarnkar VR, Porter P.

Conf Proc IEEE Eng Med Biol Soc. 2017 Jul;2017:4578-4581. doi: 10.1109/EMBC.2017.8037875.

PMID:
29060916
11.

Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.

Marso SP, McGuire DK, Zinman B, Poulter NR, Emerson SS, Pieber TR, Pratley RE, Haahr PM, Lange M, Brown-Frandsen K, Moses A, Skibsted S, Kvist K, Buse JB; DEVOTE Study Group.

N Engl J Med. 2017 Aug 24;377(8):723-732. doi: 10.1056/NEJMoa1615692. Epub 2017 Jun 12.

12.

Spatially explicit methodology for coordinated manure management in shared watersheds.

Sharara M, Sampat A, Good LW, Smith AS, Porter P, Zavala VM, Larson R, Runge T.

J Environ Manage. 2017 May 1;192:48-56. doi: 10.1016/j.jenvman.2017.01.033. Epub 2017 Jan 28.

13.
14.

Analysis of ROR1 Protein Expression in Human Cancer and Normal Tissues.

Balakrishnan A, Goodpaster T, Randolph-Habecker J, Hoffstrom BG, Jalikis FG, Koch LK, Berger C, Kosasih PL, Rajan A, Sommermeyer D, Porter PL, Riddell SR.

Clin Cancer Res. 2017 Jun 15;23(12):3061-3071. doi: 10.1158/1078-0432.CCR-16-2083. Epub 2016 Nov 16.

15.

Preferential uptake of antioxidant carbon nanoparticles by T lymphocytes for immunomodulation.

Huq R, Samuel EL, Sikkema WK, Nilewski LG, Lee T, Tanner MR, Khan FS, Porter PC, Tajhya RB, Patel RS, Inoue T, Pautler RG, Corry DB, Tour JM, Beeton C.

Sci Rep. 2016 Sep 22;6:33808. doi: 10.1038/srep33808.

16.

Plasma equol concentration is not associated with breast cancer and fibrocystic breast conditions among women in Shanghai, China.

Atkinson C, Ray RM, Li W, Lin MG, Gao DL, Shannon J, Stalsberg H, Porter PL, Frankenfeld CL, Wähälä K, Thomas DB, Lampe JW.

Nutr Res. 2016 Aug;36(8):863-71. doi: 10.1016/j.nutres.2016.03.008. Epub 2016 Mar 30.

17.

Improving Breast Ultrasound Interpretation in Uganda Using a Condensed Breast Imaging Reporting and Data System.

Scheel JR, Peacock S, Orem J, Bugeza S, Muyinda Z, Porter PL, Wood WC, Comis RL, Lehman CD.

Acad Radiol. 2016 Oct;23(10):1271-7. doi: 10.1016/j.acra.2016.05.018. Epub 2016 Jun 17.

PMID:
27325412
18.

Reproductive Factors and Risk of Luminal, HER2-Overexpressing, and Triple-Negative Breast Cancer Among Multiethnic Women.

Chen L, Li CI, Tang MT, Porter P, Hill DA, Wiggins CL, Cook LS.

Cancer Epidemiol Biomarkers Prev. 2016 Sep;25(9):1297-304. doi: 10.1158/1055-9965.EPI-15-1104. Epub 2016 Jun 15.

19.

Body mass index and risk of luminal, HER2-overexpressing, and triple negative breast cancer.

Chen L, Cook LS, Tang MT, Porter PL, Hill DA, Wiggins CL, Li CI.

Breast Cancer Res Treat. 2016 Jun;157(3):545-54. doi: 10.1007/s10549-016-3825-9. Epub 2016 May 24.

20.

An unsupervised MVA method to compare specific regions in human breast tumor tissue samples using ToF-SIMS.

Bluestein BM, Morrish F, Graham DJ, Guenthoer J, Hockenbery D, Porter PL, Gamble LJ.

Analyst. 2016 Mar 21;141(6):1947-57. doi: 10.1039/c5an02406d.

Supplemental Content

Loading ...
Support Center